Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Receivables: 2016-2025

Historic Change in Receivables for Fortress Biotech (FBIO) over the last 10 years, with Sep 2025 value amounting to $2.4 million.

  • Fortress Biotech's Change in Receivables rose 175.37% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 98.23%. This contributed to the annual value of -$4.5 million for FY2024, which is 64.35% up from last year.
  • As of Q3 2025, Fortress Biotech's Change in Receivables stood at $2.4 million, which was up 185.58% from -$2.8 million recorded in Q2 2025.
  • Fortress Biotech's Change in Receivables' 5-year high stood at $8.0 million during Q1 2022, with a 5-year trough of -$10.4 million in Q2 2023.
  • For the 3-year period, Fortress Biotech's Change in Receivables averaged around -$858,545, with its median value being -$466,000 (2023).
  • Within the past 5 years, the most significant YoY rise in Fortress Biotech's Change in Receivables was 14,170.59% (2023), while the steepest drop was 10,538.55% (2023).
  • Over the past 5 years, Fortress Biotech's Change in Receivables (Quarterly) stood at -$8.5 million in 2021, then soared by 99.40% to -$51,000 in 2022, then surged by 14,170.59% to $7.2 million in 2023, then crashed by 110.41% to -$747,000 in 2024, then soared by 175.37% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, -$2.8 million for Q2 2025, and $8.0 million during Q1 2025.